Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
In Stock • people bought this
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
It is a combination medication that belongs to a class of drugs used to treat hypertension (high blood pressure). It is used to lower high blood pressure, reducing the risk of heart attacks, strokes, and kidney problems.
Chlorthalidone, a diuretic, removes excess water and electrolytes through urine, relaxes blood vessels, and improves blood flow. Metoprolol Succinate, a beta-blocker, slows down the heart rate. Telmisartan, a calcium channel blocker, relaxes blood vessels by blocking the hormone angiotensin.
Consult to your doctor before taking this drug.
How Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s works
Metosartan CH works through a triple-action mechanism to control high blood pressure effectively. **Chlorthalidone** promotes the excretion of excess sodium and water from the body, reducing blood volume and gradually relaxing blood vessels. **Metoprolol Succinate** decreases the heart rate and cardiac output by selectively blocking beta-1 receptors, thereby reducing the workload on the heart. **Telmisartan**, an angiotensin II receptor blocker (ARB), prevents blood vessel constriction and lowers aldosterone levels, which helps in relaxing the arteries and minimizing fluid retention. Together, these actions target the three key drivers of hypertension—fluid overload, increased heart activity, and vascular resistance—for comprehensive and sustained blood pressure control.
How To Use Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
- Adult Start Dose: 1 ER tablet daily, with or after food.
- Administration: Swallow whole, without crushing, chewing, or splitting
- Timing: Take at same time each day for steady dosing.
- Monitoring: Have regular check-ups to assess blood pressure, electrolytes, kidney function, and heart rate.
Benefits Of Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
- This drug lowers blood pressure and decreases the risk of heart attacks, strokes, and kidney problems in the long term.
- Although you may not feel immediate effects, it helps keep you healthy when taken regularly.
Uses of Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
- Hypertension (high blood pressure)
Side Effects Of Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Weakness
- Cold extremities
- Numbness of extremity
- Increased uric acid level in blood
- Increased blood lipid level
- Decreased magnesium level in blood
- Slow heart rate
- Decreased sodium level in blood
- Decreased blood pressure
Disease Explanation
NA
Safety Advice for Metosartan CH 12.5mg/25mg/40mg Tablet ER 10s
- High risk
- Moderate risk
- Safe
Avoid alcohol consumption with this drug.
It is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
It is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
It should be used with caution in patients with severe kidney disease. Dose adjustment of Metosartan CH 25 Tablet ER may be needed. Please consult your doctor. Use of this drug is not recommended in these patients.
It should be used with caution in patients with liver disease. Dose adjustment of Metosartan CH 25 Tablet ER may be needed. Please consult your doctor. Use of this drug is not recommended in patients with severe liver disease.
Written By
Harsh Thakur
Content Updated on
Tuesday, 24 June, 2025
